Form 4: HCA Healthcare EVP Michael S. Cuffe Executes Stock Appreciation Rights and Sells Shares Under 10b5-1 Plan

Michael S. Cuffe, EVP and Chief Clinical Officer of HCA Healthcare, exercised stock appreciation rights and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 10, 2024, Michael S. Cuffe, EVP and Chief Clinical Officer of HCA Healthcare, exercised stock appreciation rights, acquiring 22,080 shares of common stock at a price of $145.24.
• Simultaneously, 13,722 shares were disposed of to cover tax obligations at $386.43.
• On September 12, 2024, Cuffe sold 8,358 shares of common stock at a price of $385.42.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on May 7, 2024.
• Following these transactions, Cuffe directly owns 29,678.2085 shares of HCA Healthcare common stock, which includes 2,518.2085 shares acquired under the Issuer's employee stock purchase plans.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document primarily reports on stock transactions by an executive under a pre-arranged plan. There are no explicit positive or negative implications for the company's performance.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Executive stock transactions are common and closely monitored in the healthcare industry to ensure compliance with securities regulations and to provide transparency to investors.

Comparison to Industry Standards

• Executive compensation packages often include stock options and appreciation rights to align management's interests with those of shareholders.
• Rule 10b5-1 trading plans are a standard practice for corporate insiders to manage their stock transactions and avoid accusations of insider trading.
• Comparable companies in the healthcare sector, such as UnitedHealth Group and CVS Health, also have executives who utilize similar trading plans.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-arranged nature of the trades mitigates concerns about insider information.

Key Dates